BIOMARIN PHARMA earnings per share and revenue

BM8 earnings per share for the last quarter are 0.47 CHF whereas the estimation was 0.45 CHF which accounts for 3.59% surprise. Company revenue for the same period amounts to 631.96 M CHF despite the estimated figure of 596.11 M CHF. Estimated earnings per share for the next quarter are 0.49 CHF, and revenue is expected to reach 632.08 M CHF. Also watch annual changes over time to get a bigger picture of BM8 earnings per share and revenue dynamics.